Hydroxychloroquine

Pathogenesis-Directed Lupus Therapeutics

A 2026 review of pathogenesis-directed SLE therapeutics anchored to the 2025 ACR SLE and 2024 ACR lupus nephritis guidelines — the FDA-approved and off-label drugs by mechanism, indication and monitoring, plus the metabolic/mitochondrial, IL-1, cardiometabolic and non-pharmacological strategies, mapped by organ manifestation.

June 21, 2026 · 8 min

Fertility, Pregnancy and Lactation in Women with SLE

A 2026 narrative review of fertility, pregnancy and lactation in SLE — the bidirectional disease–pregnancy relationship, the immunobiology of placental injury, and contemporary peri-conception, pregnancy and lactation care anchored to BSR, EULAR and ACR guidance, including a drug-by-drug safety framework.

June 14, 2026 · 8 min
Independent educational summaries for healthcare professionals. Not medical advice. Each post is an original summary of the cited source; copyright in the original works remains with their authors and publishers. See the About & Disclaimer page.